KDR and chronic myelogenous leukemia, BCR-ABL1 positive: In the same view, VEGFR-2 rs1870377A polymorphism was associated with better prognosis in two studies regarding lymphoma diffuse large B-cell [31] and chronic myeloid leukemia with imatinib therapy.